Cadence Neuroscience is an early-stage company developing medical device therapies for epilepsy.
Cadence Neuroscience has raised $26.0M in total funding. The most recent round was Series B. The last funding was announced in February 2023.
Cadence Neuroscience's investors include F-Prime, Mayo Clinic, LivaNova, Jazz Venture Partners, Angelini Ventures.
Cadence Neuroscience is headquartered in Redmond, United States.
Cadence Neuroscience is an early-stage company developing medical device therapies for epilepsy.
Cadence Neuroscience is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cadence Neuroscience — Funding & Investors." VCBacked, February 28, 2023, https://www.vcbacked.co/company/cadence-neuroscience. Accessed August 14, 2026.
VCBacked. (2023). Cadence Neuroscience — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cadence-neuroscience
{{cite web |title=Cadence Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/cadence-neuroscience |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated